Does adding prednisolone help reduce coronary artery lesions in newly diagnosed patients?
Kawasaki disease is a childhood illness that causes inflammation in blood vessels, including the coronary arteries. A key concern is preventing coronary artery lesions (CAL), which can lead to long-term heart problems. Standard treatment includes intravenous immunoglobulin (IVIG) and aspirin. Some doctors have considered adding corticosteroids like prednisolone to reduce inflammation further. However, a large, recent trial provides clear evidence on whether this helps prevent CAL in newly diagnosed patients.
What the research says
A large randomized controlled trial involving 3,208 participants with newly diagnosed Kawasaki disease directly tested whether adding prednisolone to standard treatment reduces coronary artery lesions 6. The study found that at 1 month after illness onset, coronary artery lesions occurred in 16.0% of patients receiving prednisolone plus standard treatment and in 13.8% of those receiving standard treatment alone 6. This difference was not statistically significant, meaning the addition of prednisolone did not meaningfully reduce the risk of CAL 6. The trial also noted that prednisolone did help shorten fever duration and reduce the need for rescue therapy, but these benefits did not translate into fewer coronary lesions 6. Other sources on Kawasaki disease focus on different aspects: one study explores lab indicators to predict CAL 2, another uses machine learning for prediction 3, and a case report discusses infliximab for IVIG-resistant cases 5. None of these directly address the question of adding prednisolone for newly diagnosed patients, but they highlight the complexity of managing CAL risk. Importantly, the trial's finding is specific to unselected, newly diagnosed patients and does not apply to those who are resistant to initial IVIG treatment 6.
What to ask your doctor
- Based on the latest evidence, does adding prednisolone to standard treatment offer any benefit for my child's specific case?
- What are the potential side effects of prednisolone, and how do they compare to the possible benefits?
- If my child has risk factors for coronary artery lesions, are there other treatments or monitoring strategies that might be more effective?
- How will you monitor my child for coronary artery lesions during and after treatment?
- Are there any ongoing studies or newer treatments for Kawasaki disease that might be relevant?
This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.